AIM ImmunoTech Inc. SEC filings AIM

AIM ImmunoTech Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 6, 2013. Its latest annual report, Form ARS, was filed on Sep 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Sep 30, 2026 Dec 31, 2025
10-K Annual report Mar 27, 2026 Dec 31, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K Annual report Mar 31, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
10-K Annual report Apr 1, 2019 Dec 31, 2018
10-K Annual report Mar 30, 2018 Dec 31, 2017
10-K Annual report Mar 31, 2017 Dec 31, 2016
10-K Annual report Mar 29, 2016 Dec 31, 2015
10-K/A Amended annual report Mar 20, 2015 Dec 31, 2014
10-K Annual report Mar 19, 2015 Dec 31, 2014
10-K Annual report Mar 14, 2014 Dec 31, 2013

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
AIM (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Ocala, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
946644
Former names
AIM ImmunoTech Inc. (until Nov 5, 2026); HEMISPHERX BIOPHARMA INC (until Aug 26, 2019)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.